Methotrexate

• Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point… Ended
  2024-511530-12-01 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• Phase IIa Proof-of-Concept Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients with Rheumatoid Arthritis Ended
  2023-510258-17-00 Phase II 1 country Solfarcos Solucoes Farmaceuticas E Cosmeticas Lda.
• MTR² Ended
  2022-502790-42-00 Phase II 1 country University Of Cologne
• The MERINO trial Ended
  2023-510523-30-00 Phase IV 1 country Diakonhjemmet Sykehus AS
• Efficacy and Safety of Methotrexate versus Placebo in Adults with Atopic Dermatitis Ended
  2023-504443-13-00 Phase III 4 countries Medac Gesellschaft fuer klinische Spezialprapaerate mbH
• Efficacy, tolerability and preferences of per oral or subcutaneous methotrexate in patients with early rheumatoid arthritis – a randomised r… Ended
  2024-512453-25-00 Phase IV 1 country Region Vaesterbotten
• The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended
  2023-508968-30-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
• AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended
  2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland
• The aim of the study is to evaluate the efficacy of Ponatinib, either alone or in combination with chemotherapy, in inducing remission in pa… Ended
  2024-516868-28-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• A clinical trial evaluating the efficacy and safety of the drugs - cyclosporine and methotrexate in children and adolescents with moderate t… Ended
  2023-509759-15-00 Phase III 1 country Medical University Of Lodz
• Methotrexate and Metformin in rheumatoid arthritis patients. Ended
  2024-511033-35-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
• MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Ended
  2024-512269-14-00 Phase III 1 country Centre Hospitalier Universitaire De Dijon
• STOP-I-SEP_Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 years Ended
  2024-516628-32-00 Phase III 1 country Centre Hospitalier Universitaire De Rennes
• International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended
  2024-513070-21-00 Phase II 11 countries Charite Universitaetsmedizin Berlin KöR
• International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended
  2024-515499-12-00 Phase III 12 countries Universita Degli Studi Di Milano Bicocca
• B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended
  2023-505509-18-00 Phase III 7 countries Universitaetsklinikum Muenster AöR
• HOVON 127 BL / SAKK 37/16: Phase III study comparing 2 treatments (R-CODOX-M/R-IVAC versus DA-EPOCH-R) in patients with Burkitt lymphoma Ended
  2023-503423-25-00 Phase III 2 countries Haemato Oncology Foundation For Adults Netherlands
• Salvage Therapy for Patients with Inadequate Response to Standard of Care Therapy in Granulomatosis with Polyangiitis Halted
  2024-516687-28-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• A phase 1/2 study of subcutaneous blinatumomab administration in adults and adolescents with R/R and MRD+ B-ALL Halted
  2023-506136-32-00 Phase I/II 7 countries Amgen Inc.
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous CT-P13 in … Ended
  2024-510945-32-00 Phase III 1 country Celltrion Inc.
• A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral AP118… Ended
  2024-514981-37-00 Phase II 5 countries Synact Pharma ApS
• A randomised, double-blind, multicentre study comparing the efficacy, safety and immunogenicity of proposed Abatacept biosimilar (DRL_AB) wi… Ended
  2023-506664-14-00 Phase III 8 countries Dr Reddy's Laboratories Limited
• A study to evaluate SAR441566 efficacy and safety in adults with rheumatoid arthritis Ended
  2023-503910-60-00 Phase II 6 countries Sanofi-Aventis Recherche & Developpement
• A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of concept Study Evaluating the Efficacy and Safety of Nipocalimab and Cer… Ended
  2023-504045-31-00 Phase II 3 countries Janssen - Cilag International

Showing 49–72 of 77 trials